Molecular diagnostics : for the clinical laboratorian

Part I. Introduction An Historical Perspective on the Clinical Diagnostic Laboratory Robert E. Moore Part II. Basic Molecular Biology An Overview of Nucleic Acid Chemistry, Structure, and Function: The Foundations of Molecular Biology William B. Coleman Extraction of Nucleic Acids Paul N. Bogner and Anthony A. Killeen Nucleic Acid Blotting Techniques: Theory and Practice Terry Amiss and Sharon Collins Presnell The Polymerase Chain Reaction William B. Coleman and Gregory J. Tsongalis Bioinformatics: Computer-Based Approaches to Genetic Analysis Sharon L. Ricketts Part III. Molecular Diagnostic Technologies PCR-Based Methods for Mutation Detection Ian M. Frayling, Emma Monk, and Rachel Butler Alternative Methods for Amplified Nucleic Acid Testing Deborah A. Payne and Laurie E. Sower Electrophoretic Methods for Mutation Detection and DNA Sequencing W. Edward Highsmith, Jr. Single-Nucleotide Polymorphisms: Testing DNA Variation for Disease Association Ulrich Broeckel and Martin J. Hessner Microarray Approaches to Gene Expression Analysis David Neil Hayes and Matthew Meyerson Methods for Analysis of DNA Methylation Alexander Dobrovic Part IV. Other Clinical Diagnostic Technologies Flow Cytometry Joseph A. DiGiuseppe Medical Cytogenetics Martha B. Keagle Fluorescence In Situ Hybridization: A Major Milestone in Luminous Cytogenetics Suneel D. Mundle and Robert J. Koska Immunohistochemistry John Hunt, Larissa Davydova, Richard W. Cartun, and Maria Baiulescu Laser Capture Microdissection C. Robert Bagnell, Jr. Part V. Quality Assurance in the Molecular Diagnostics Laboratory Framework for Quality Assurance in Molecular Diagnostics Marlene Sabbath-Solitare, Selwyn J. Baptist, and Teresita Cuyegkeng Redondo Verification of Molecular Assays Brent L. Seaton Standards and Standardization of Molecular Diagnostics John P. Jakupciak and Catherine D. O'Connell Laboratory-Developed Tests in Molecular Diagnostics Andrea Ferreira-Gonzalez and Carleton T. Garrett Part VI. Applications of Molecular Diagnostics for Genetic Diseases An Overview of Molecular Genetics Elaine Weidenhammer and Gregory J. Tsongalis Genetic Basis of Neurologic and Neuromuscular Diseases Narasimhan Nagan, Christopher J. Klein, D. Brian Dawson, Myra J. Wick, and Stephen N. Thibodeau Molecular Mechanisms of Endocrine Disorders Amy Potter and John A. Phillips III Molecular Pathogenesis of Cardiovascular Disease Alan H. B. Wu Molecular Diagnostics in Coagulation Enrique Ballesteros Cystic Fibrosis Eugene H. Lewis III, Myra J. Lewis, Jean A. Amos, and Gregory J. Tsongalis Prenatal Genotyping for Identification of Fetuses at Risk for Immune Cytopenic Disorders Martin J. Hessner and Brian R. Curtis Personalized Medicine, Karen McCullough Part VII. Applications of Molecular Diagnostics for Human Cancers Molecular Pathogenesis of Human Cancer William B. Coleman and Gregory J. Tsongalis Application of Molecular Diagnostics to Hereditary Nonpolyposis Colorectal Cancer Ian M. Frayling, Lisa Happerfield, Christopher Mattocks, Kim Oakhill, and Mark J. Arends Molecular Genetic Applications to the Diagnosis of Lymphoma William N. Rezuke, Jr. and Gregory J. Tsongalis Molecular Genetic Abnormalities in Acute and Chronic Leukemias Pei Lin and L. Jeffrey Medeiros Part VIII. Applications of Molecular Diagnostics for Infectious Diseases Molecular Testing for Chlamydia trachomatis and Neisseria gonorrhoeae Alexandra Valsamakis Human Papillomavirus Theresa M. Voytek and Gregory J. Tsongalis

[1]  R. Jones,et al.  Immunological Properties of an Antibody Containing a Fluorescent Group.∗ , 1941 .

[2]  C. Taylor,et al.  The demonstration of plasma cells and other immunoglobulin-containing cells in formalin-fixed, paraffin-embedded tissues using peroxidase-labelled antibody , 1974, Journal of clinical pathology.

[3]  S. Huang Immunohistochemical demonstration of hepatitis B core and surface antigens in paraffin sections. , 1975, Laboratory investigation; a journal of technical methods and pathology.

[4]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[5]  R. M. Schmidt,et al.  Stigmatization of carrier status: social implications of heterozygote genetic screening programs. , 1978, American journal of public health.

[6]  C. Marsden,et al.  Attitudes of families to some aspects of Huntington's chorea , 1979, Psychological Medicine.

[7]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[8]  P. Harper,et al.  Genetic prediction and family structure in Huntington's chorea. , 1985, British medical journal.

[9]  C. Croce,et al.  Chromosome translocations and human cancer. , 1985, Scientific American.

[10]  K. Lennert,et al.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. , 1985, Blood.

[11]  S. J. Bird Presymptomatic testing for Huntington's disease. , 1985, JAMA.

[12]  L. Farrer Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk. , 1986, American journal of medical genetics.

[13]  M. Koenig,et al.  Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.

[14]  A. Monaco,et al.  Cloning of the Duchenne/Becker muscular dystrophy locus. , 1988, Advances in human genetics.

[15]  K. Klinger,et al.  Predictive testing for Huntington's disease with use of a linked DNA marker. , 1988, The New England journal of medicine.

[16]  S. Folstein,et al.  Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease. , 1989, JAMA.

[17]  J. Cassiman,et al.  The motivation of at‐risk individuals and their partners in deciding for or against predictive testing for Huntington's disease , 1989, Clinical genetics.

[18]  T. Harris,et al.  Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. , 1989, Journal of immunological methods.

[19]  L. Kunkel,et al.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. , 1989, American journal of human genetics.

[20]  D. Craufurd,et al.  UPTAKE OF PRESYMPTOMATIC PREDICTIVE TESTING FOR HUNTINGTON'S DISEASE , 1989, The Lancet.

[21]  C R King,et al.  Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Ann M. Johnson,et al.  Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease. , 1990, American journal of medical genetics.

[23]  B. Vogelstein,et al.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.

[24]  Kathleen R. Cho,et al.  Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.

[25]  A. Pestronk,et al.  Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group. , 1991, Archives of neurology.

[26]  M. Key,et al.  Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[27]  K. Kinzler,et al.  Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. , 1991, Science.

[28]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[29]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[30]  G. Bruyn,et al.  Age at onset in Huntington's disease: effect of line of inheritance and patient's sex. , 1991, Journal of medical genetics.

[31]  J. Ervasti,et al.  Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.

[32]  A. Yu,et al.  Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms. Results of an intergroup rhabdomyosarcoma study project , 1991, Cancer.

[33]  J. Phillips,et al.  Presymptomatic testing for adult onset polycystic kidney disease in at-risk kidney transplant donors. , 1991, American journal of medical genetics.

[34]  S. Altschul,et al.  Identification of FAP locus genes from chromosome 5q21. , 1991, Science.

[35]  A. Pestronk,et al.  Long‐term benefit from prednisone therapy in Duchenne muscular dystrophy , 1991, Neurology.

[36]  Joe C. Adams,et al.  Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[37]  G. Wahl,et al.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles , 1992, Cell.

[38]  M. Hayden,et al.  Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. , 1992, American journal of medical genetics.

[39]  T M Grogan,et al.  Automated immunohistochemical analysis. , 1992, American journal of clinical pathology.

[40]  A. Velázquez,et al.  Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Thea D. Tlsty,et al.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 , 1992, Cell.

[42]  W. King,et al.  Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. , 1993, Human molecular genetics.

[43]  Robin J. Leach,et al.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.

[44]  Darryl Shibata,et al.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.

[45]  M. Hayden,et al.  Attitudes Toward Direct Predictive Testing for the Huntington Disease Gene: Relevance for Other Adult-Onset Disorders , 1993 .

[46]  D. Bentley,et al.  Exon structure of the human dystrophin gene. , 1993, Genomics.

[47]  Bert Vogelstein,et al.  Hypermutability and mismatch repair deficiency in RER+ tumor cells , 1993, Cell.

[48]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[49]  M. Hollstein,et al.  Clinical implications of the p53 tumor-suppressor gene. , 1993, The New England journal of medicine.

[50]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. , 1993, Cell.

[51]  M. Oren Relationship of p53 to the control of apoptotic cell death. , 1994, Seminars in cancer biology.

[52]  E. Eichler,et al.  Length of uninterrupted CGG repeats determines instability in the FMR1 gene , 1994, Nature Genetics.

[53]  M. Götz,et al.  Utilization of prenatal diagnosis for cystic fibrosis over the past seven years. , 1994, Pediatrics.

[54]  A. Bateman,et al.  immunocytochemistry: a study of 80 antibodies , 2022 .

[55]  Y S Erozan,et al.  Microsatellite alterations as clonal markers for the detection of human cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[56]  N. Holtzman,et al.  Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. , 1994, American journal of human genetics.

[57]  F. Askin,et al.  Ewing's sarcoma--routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. , 1994, Human pathology.

[58]  J. Brandt,et al.  Self-selection in predictive testing for Huntington's disease. , 1994, American journal of medical genetics.

[59]  J. Brandt,et al.  Psychological costs and benefits of predictive testing for Huntington's disease. , 1994, American journal of medical genetics.

[60]  H. Satoh,et al.  Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. , 1994, Blood.

[61]  M. Daly,et al.  Attitudes about genetic testing for breast-ovarian cancer susceptibility. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  Y. Nakamura,et al.  Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. , 1994, Cancer Research.

[63]  L. Hartwell,et al.  Cell cycle control and cancer. , 1994, Science.

[64]  D N Shapiro,et al.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.

[65]  T. Triche,et al.  The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. , 1994, The New England journal of medicine.

[66]  M. Modell,et al.  The impact of population based screening for carriers of cystic fibrosis. , 1994, Journal of medical genetics.

[67]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[68]  R. Fleischmann,et al.  Mutation of a mutL homolog in hereditary colon cancer. , 1994, Science.

[69]  R. Cote,et al.  Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques , 1994, Human pathology.

[70]  L. Augenlicht,et al.  Presence and instability of repetitive elements in sequences the altered expression of which characterizes risk for colonic cancer. , 1995, Cancer research.

[71]  G. Cattoretti,et al.  Antigen Unmasking on Formalin‐Fixed Paraffin‐Embedded Tissues Using Microwaves: A Review , 1995 .

[72]  A. Gown,et al.  Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. , 1995, The American journal of pathology.

[73]  K. Gatter,et al.  Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist , 1995 .

[74]  S. Thibodeau,et al.  Genomic instability in neoplasia. , 1995, Seminars in cell biology.

[75]  P. Delrio,et al.  Microsatellite instability and pathological aspects of breast cancer , 1995, International journal of cancer.

[76]  T. Tlsty,et al.  Genomic instability and cancer. , 1995, Mutation research.

[77]  K. Kinzler,et al.  Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. , 1995, Cancer research.

[78]  N. Harris,et al.  Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. , 1995, American journal of clinical pathology.

[79]  J. Lasota,et al.  Bcl‐2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B‐cell proliferations is of diagnostic value , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[80]  P. Modrich,et al.  Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[81]  M. Mori,et al.  Microsatellite instability in multiple gastric cancers , 1995, International journal of cancer.

[82]  Asad Umar,et al.  A hPMS2 Mutant Cell Line Is Defective in Strand-specific Mismatch Repair (*) , 1995, The Journal of Biological Chemistry.

[83]  R I Richards,et al.  Simple tandem DNA repeats and human genetic disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[84]  M. Hayden,et al.  Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes. , 1995, American journal of human genetics.

[85]  C. Boland,et al.  Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. , 1995, Journal of the National Cancer Institute.

[86]  R. Zarbo,et al.  Evaluation of anti-p53 antibody staining immunoreactivity in benign tumors and nonneoplastic tissues , 1995 .

[87]  B. Trock,et al.  BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. , 1996, JAMA.

[88]  F. Niggli,et al.  Detection of t(11;22)(q24;ql2) Translocation Breakpoint in Paraffin‐embedded Tissue of the Ewing's Sarcoma Family by Nested Reverse Transcription‐Polymerase Chain Reaction , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[89]  T. Iwama,et al.  Frequent Microsatellite Instabilities and Analyses of the Related Genes in Familial Gastric Cancers , 1996, Japanese journal of cancer research : Gann.

[90]  G. Petersen,et al.  Genetic testing and counseling in familial adenomatous polyposis. , 1996, Oncology.

[91]  R. Benezra,et al.  Identification of a Human Mitotic Checkpoint Gene: hsMAD2 , 1996, Science.

[92]  C. Harris,et al.  Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. , 1996, Journal of the National Cancer Institute.

[93]  T. Kunkel,et al.  Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair , 1996, Nature Genetics.

[94]  G. Wahl,et al.  Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. , 1996, Cancer research.

[95]  J. Rüschoff,et al.  GENOMIC INSTABILITY IN COLORECTAL CARCINOMAS: COMPARISON OF DIFFERENT EVALUATION METHODS AND THEIR BIOLOGICAL SIGNIFICANCE , 1996, The Journal of pathology.

[96]  T. Hansen,et al.  Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3) , 1996, Nature.

[97]  M. Pignatelli,et al.  The molecular histology of neoplasia: the role of the cadherin/catenin complex , 1997, Histopathology.

[98]  L. Shaffer,et al.  Diagnosis of CMT1A duplications and HNPP deletions by interphase FISH: implications for testing in the cytogenetics laboratory. , 1997, American journal of medical genetics.

[99]  R. Cote,et al.  Immunohistochemical markers of prognostic value in surgical pathology. , 1997, Histology and histopathology.

[100]  J. Gebert,et al.  Microsatellite instability analysis: a multicenter study for reliability and quality control. , 1997, Cancer research.

[101]  I. Moore,et al.  Immunohistochemical detection of the Wilms’ tumour gene WT1 in desmoplastic small round cell tumour , 1997, Histopathology.

[102]  H. Ackermann,et al.  Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer , 1997, Oncogene.

[103]  G. Bell,et al.  Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. , 1997, Nature genetics.

[104]  R. Cote,et al.  Antigen Retrieval Immunohistochemistry: Past, Present, and Future , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[105]  J. Rüschoff,et al.  Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. , 1997, Cancer research.

[106]  W. Chan,et al.  Clonality in nodular lymphocyte-predominant Hodgkin's disease. , 1997, The New England journal of medicine.

[107]  P. Peltomäki DNA mismatch repair gene mutations in human cancer. , 1997, Environmental health perspectives.

[108]  R. Alsabeh,et al.  Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method. , 1997, American journal of clinical pathology.

[109]  R. Turner,et al.  Mutations in the Hepatocyte Nuclear Factor-1α Gene in MODY and Early-Onset NIDDM: Evidence for a Mutational Hotspot in Exon 4 , 1997, Diabetes.

[110]  T. Kunkel,et al.  Mismatch repair in extracts of Werner syndrome cell lines. , 1997, Cancer research.

[111]  R. Mariani-Costantini,et al.  Microsatellite instability is correlated with lymph node-positive breast cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[112]  R. Croyle,et al.  Genetic counseling issues , 1997 .

[113]  G. Thomas,et al.  BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. , 1997, Cancer research.

[114]  William L. Clarke,et al.  Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence , 1997, Nature Genetics.

[115]  W. Clarke,et al.  Early-onset type-ll diabetes mellitus (MODY4) linked to IPF1 , 1997, Nature Genetics.

[116]  Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. , 1997 .

[117]  M. MacDonald,et al.  Reduced penetrance of the Huntington's disease mutation. , 1997, Human molecular genetics.

[118]  S. Bundey Few psychological consequences of presymptomatic testing for Huntington disease , 1997, The Lancet.

[119]  B. Devellis,et al.  Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients. , 1997, American journal of medical genetics.

[120]  T. McIntosh,et al.  The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. , 1998, The Journal of clinical investigation.

[121]  A. Middleton,et al.  Attitudes of deaf adults toward genetic testing for hereditary deafness. , 1998, American journal of human genetics.

[122]  Jian Kuang,et al.  Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation , 1998, Nature Genetics.

[123]  N. Ordóñez Desmoplastic small round cell tumor: II: an ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers. , 1998, The American journal of surgical pathology.

[124]  D. Schaid,et al.  Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. , 1998, Cancer research.

[125]  J. Takeda,et al.  Frameshift Mutation, A263fsinsGG, in the Hepatocyte Nuclear Factor-1β Gene Associated With Diabetes and Renal Dysfunction , 1998, Diabetes.

[126]  T. Kunkel,et al.  Characterization of Distinct Human Endometrial Carcinoma Cell Lines Deficient in Mismatch Repair That Originated from a Single Tumor* , 1998, The Journal of Biological Chemistry.

[127]  W. Gerald,et al.  Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[128]  S. Schwartz,et al.  Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53 , 1998, Oncogene.

[129]  K. Hoang-Xuan,et al.  Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites , 1998, Genes, chromosomes & cancer.

[130]  S. Pileri,et al.  The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. , 1998, Journal of clinical pathology.

[131]  K. Aldape,et al.  An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[132]  M. Vyberg,et al.  Dextran Polymer Conjugate Two-Step Visualization System for Immunohistochemistry: A Comparison of EnVision+ With Two Three-Step Avidin-Biotin Techniques , 1998 .

[133]  N. Holtzman,et al.  Decision-making about breast cancer susceptibility testing: how similar are the attitudes of physicians, nurse practitioners, and at-risk women? , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[134]  V. Golubovskaya,et al.  Chromosomal instability is correlated with telomere erosion and inactivation of G2 checkpoint function in human fibroblasts expressing human papillomavirus type 16 E6 oncoprotein , 1998, Oncogene.

[135]  Christine Yoshinaga-Itano,et al.  Language of Early- and Later-identified Children With Hearing Loss , 1998, Pediatrics.

[136]  S. Hirota,et al.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. , 1998, Science.

[137]  R. Croyle,et al.  The new genetics: Psychological responses to genetic testing , 1998 .

[138]  A Truchaud,et al.  Comparative evaluation of automated systems in immunohistochemistry. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[139]  C. Canman,et al.  The role of ATM in DNA damage responses and cancer , 1998, Oncogene.

[140]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[141]  Rotterdam,et al.  Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup. , 1998, Journal of medical genetics.

[142]  Hongbing Zhang,et al.  BRCA1, BRCA2, and DNA Damage Response: Collision or Collusion? , 1998, Cell.

[143]  B. Vogelstein,et al.  Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. , 1998, The American journal of pathology.

[144]  Chan,et al.  Immunostaining for cyclin D1 and the diagnosis of mantle cell lymphoma: is there a reliable method? , 1999, Histopathology.

[145]  C. Amos,et al.  Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancer. , 1999, Oncology reports.

[146]  Y. Shiratori,et al.  Mutational Inactivation of Mitotic Checkpoint Genes, hsMAD2 and hBUB1, Is Rare in Sporadic Digestive Tract Cancers , 1999, Japanese journal of cancer research : Gann.

[147]  A. Ashworth,et al.  Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification , 1999, Current Biology.

[148]  H. Mori,et al.  Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. , 1999, Cancer research.

[149]  Patrick E Carroll,et al.  Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression , 1999, Oncogene.

[150]  T. Bird Outrageous fortune: the risk of suicide in genetic testing for Huntington disease. , 1999, American journal of human genetics.

[151]  V. Sheffield,et al.  Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. , 1999, JAMA.

[152]  Clive R. Taylor,et al.  Sensitivity and detection efficiency of a novel two-step detection system (PowerVision) for immunohistochemistry , 1999 .

[153]  Z. Cohen,et al.  Negative genetic test result in familial adenomatous polyposis , 1999, Diseases of the colon and rectum.

[154]  J. Allanson,et al.  Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer , 1999, Clinical genetics.

[155]  A. Gown,et al.  Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[156]  G Flandrin,et al.  World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[157]  K. Kinzler,et al.  Characterization of MAD2B and other mitotic spindle checkpoint genes. , 1999, Genomics.

[158]  D. Bowen,et al.  Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[159]  M. Kinney The role of morphologic features, phenotype, genotype, and anatomic site in defining extranodal T-cell or NK-cell neoplasms. , 1999, American journal of clinical pathology.

[160]  M. Hayden,et al.  A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. , 1999, American journal of human genetics.

[161]  J. Jen,et al.  Mutation analysis of hBUB1 in aneuploid HNSCC and lung cancer cell lines. , 1999, Cancer letters.

[162]  M. Eguchi,et al.  Defective control of apoptosis and mitotic spindle checkpoint in heterozygous carriers of ATM mutations. , 1999, Cancer research.

[163]  Paul J. Kurtin,et al.  Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry. , 1999, American journal of clinical pathology.

[164]  E. Campo,et al.  Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. , 1999, Blood.

[165]  K. Glanz,et al.  Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[166]  L. Tiret,et al.  Characterization of a Unique Genetic Variant in the β1-adrenoceptor Gene and Evaluation of its Role in Idiopathic Dilated Cardiomyopathy , 1999 .

[167]  Salma K. Marani,et al.  Intention to learn results of genetic testing for hereditary colon cancer. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[168]  R. Cartun Use of Immunohistochemistry in the Surgical Pathology Laboratory for the Diagnosis of Infectious Diseases , 1999 .

[169]  W. McKellin,et al.  ‘There’s this thing in our family’: predictive testing and the construction of risk for Huntington Disease , 1999 .

[170]  J. Nährig,et al.  Protocol for ultrarapid immunostaining of frozen sections. , 1999, Journal of clinical pathology.

[171]  Keizo Sugimachi,et al.  Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair , 1999, Oncogene.

[172]  J. Diagnostic Immunohistochemistry , 2022 .